Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 6.611B
December 31, 2024 6.118B
December 31, 2023 11.22B
December 31, 2022 10.79B
December 31, 2021 7.53B
December 31, 2020 6.660B
December 31, 2019 3.816B
December 31, 2018 3.168B
December 31, 2017 2.090B
December 31, 2016 1.497B
December 31, 2015 1.127B
December 31, 2014 1.398B
December 31, 2013 1.465B
December 31, 2012 1.391B
December 31, 2011 1.021B
December 31, 2010 1.031B
December 31, 2009 1.285B
December 31, 2008 832.10M
Date Value
December 31, 2007 460.87M
December 31, 2006 704.63M
December 31, 2005 361.16M
December 31, 2004 392.32M
December 31, 2003 583.16M
December 31, 2002 634.98M
December 31, 2001 743.20M
December 31, 2000 388.60M
December 31, 1999 187.80M
December 31, 1998 245.65M
December 31, 1997 279.67M
December 31, 1996 130.36M
December 31, 1995 86.98M
December 31, 1994 106.47M
December 31, 1993 52.10M
December 31, 1992 43.70M
December 31, 1991 51.49M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. 9.613B
Alnylam Pharmaceuticals, Inc. 2.908B
Sionna Therapeutics, Inc. 235.88M
Regeneron Pharmaceuticals, Inc. 8.611B
Biogen, Inc. 3.816B